Table 1 Demographic and clinical data of patients included in the discovery phase of the study.

From: Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation

Group

n

Gender (M/F)

Age

Schirmer I test

Squamous metaplasia grade

0

1

2

3

4

CT

18

8/10

44.6 ± 21.4

13.8 ± 3.5

13

4

1

0

0

MGD

12

5/7

54.7 ± 11.6

8.0 ± 2.2

2

4

2

2

2

DE

7

2/5

56.1 ± 14.8

1.7 ± 2.0

0

1

3

2

1

  1. CT = Control; MGD = Meibomian gland dysfunction; DE = Dry eye.
Back to article page